Grifols SA - Company Profile
Powered by 
All the data and insights you need on Grifols SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Grifols SA Strategy Report
- Understand Grifols SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Grifols SA (Grifols) is a specialty pharmaceutical company that develops, manufactures and distributes biological medicines based on plasma-derived proteins. It offers in vitro diagnostics products for use in clinical and blood bank laboratories; and nutrition products, intravenous solutions and medical devices for use in clinics and hospitals.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Grifols’ R&D activities are focused on developing products, researching new applications for existing products, and improvement of manufacturing processes to enhance yields, safety and efficiency. The company focuses on the development of in vitro diagnostic reagents, assays, instrumentation, and software for donor screening. It supports various business areas such as transfusion medicine, clinical diagnostics, and the recombinant protein business. It also focuses on the delivery of products, integrated technology solutions, and services that enhance safety, quality and efficiency in operational pharmacy. The key technologies include NAT technology and gel agglutination technology. As of December, 2022, the company had 14 R&D innovation centers. In FY2022, the company spent EUR351 million on R&D, which as a percentage of revenue stood at 5.8%. As of December 31, 2022, the company had 3,487 patents issued patents and 970 patent applications.
Business Segments
Overview
Includes all transactions related to biological products for non-therapeutic use.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Employs proteins extracted from human plasma to produce therapeutic medicines for the treatment of chronic, rare and life-threatening conditions. Its therapies treat a wide range of medical conditions, including coagulation disorders, pulmonary disorders, immune deficiencies, shock and trauma, liver cirrhosis, and infectious. The segment oversees all activities including plasma collection and manufacturing; plasma testing and analysis; R&D; manufacturing; marketing and worldwide distribution. - Key plasma products include intravenous immunoglobin; albumin; HyperRAB anti-rabies immunoglobulin; Koate-DVI, used to prevent and control bleeding in Factor VIII deficiency; and Xembify used to treat Primary Humoral Immunodeficiency. Continue to develop new formulations and indications of its therapies to meet growing needs of people across the world.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides in vitro diagnostics products, including reagents, analytical instruments, software and related products for use in clinical and blood bank laboratories. It serves clinical analysis laboratories, blood donation centers and hospital immunohematology services. The company distributes products in Europe, Asia-Pacific, North America, the Middle East, Latin America and Africa. - Key products include automated immunohematology analyzers, blood screening systems, antigens, leucored and standard blood bags, automated hemostasis analyzers, ELISA kits, coagulation reagents, instrumentation and software. Continue to grow its portfolio of clinical and diagnostic products in autoimmunity and hemostasis areas.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Includes rendering of manufacturing services to third-party companies. It also includes pharmaceutical products manufactured, and hospital pharmacies.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Target Markets
Includes the Czech Republic, France, Germany, Ireland, Italy, Poland, Portugal, Sweden, Switzerland, and Slovakia.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward